GB9321558D0 - Anti-viral agents - Google Patents

Anti-viral agents

Info

Publication number
GB9321558D0
GB9321558D0 GB939321558A GB9321558A GB9321558D0 GB 9321558 D0 GB9321558 D0 GB 9321558D0 GB 939321558 A GB939321558 A GB 939321558A GB 9321558 A GB9321558 A GB 9321558A GB 9321558 D0 GB9321558 D0 GB 9321558D0
Authority
GB
United Kingdom
Prior art keywords
viral agents
viral
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB939321558A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RADOPATH Ltd
Original Assignee
RADOPATH Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RADOPATH Ltd filed Critical RADOPATH Ltd
Priority to GB939321558A priority Critical patent/GB9321558D0/en
Publication of GB9321558D0 publication Critical patent/GB9321558D0/en
Priority to JO19941866A priority patent/JO1866B1/en
Priority to CA2123825A priority patent/CA2123825A1/en
Priority to MA23679A priority patent/MA23356A1/en
Priority to AU79437/94A priority patent/AU7943794A/en
Priority to CO94047671A priority patent/CO4520283A1/en
Priority to IL11133894A priority patent/IL111338A0/en
Priority to CZ961137A priority patent/CZ113796A3/en
Priority to EP94930272A priority patent/EP0739208A1/en
Priority to UY23844A priority patent/UY23844A1/en
Priority to CN94194350A priority patent/CN1140992A/en
Priority to EE9600057A priority patent/EE9600057A/en
Priority to ZA948191A priority patent/ZA948191B/en
Priority to HR9321558.0A priority patent/HRP940688A2/en
Priority to SK506-96A priority patent/SK50696A3/en
Priority to GB9421099A priority patent/GB2283913A/en
Priority to PCT/GB1994/002292 priority patent/WO1995011028A1/en
Priority to CA002174552A priority patent/CA2174552A1/en
Priority to PL94314008A priority patent/PL314008A1/en
Priority to BR9407862A priority patent/BR9407862A/en
Priority to JP7511518A priority patent/JPH09505804A/en
Priority to APAP/P/1994/000695A priority patent/AP620A/en
Priority to GB9804302A priority patent/GB2319474A/en
Priority to HU9601006A priority patent/HUT76322A/en
Priority to PE1994253128A priority patent/PE5596A1/en
Priority to NO961547A priority patent/NO961547L/en
Priority to OA60815A priority patent/OA10579A/en
Priority to BG100599A priority patent/BG100599A/en
Priority to MD96-0168A priority patent/MD960168A/en
Priority to GBGB9801098.6A priority patent/GB9801098D0/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB939321558A 1993-10-19 1993-10-19 Anti-viral agents Pending GB9321558D0 (en)

Priority Applications (30)

Application Number Priority Date Filing Date Title
GB939321558A GB9321558D0 (en) 1993-10-19 1993-10-19 Anti-viral agents
JO19941866A JO1866B1 (en) 1993-10-19 1994-01-19 Anti-viral agents
CA2123825A CA2123825A1 (en) 1993-10-19 1994-05-18 Anti-Viral Agents
MA23679A MA23356A1 (en) 1993-10-19 1994-10-18 ANTI-VIRAL AGENTS
PE1994253128A PE5596A1 (en) 1993-10-19 1994-10-19 ANTIVIROSICO AGENT
SK506-96A SK50696A3 (en) 1993-10-19 1994-10-19 Flavin and its derivatives as anti-viral agents
CA002174552A CA2174552A1 (en) 1993-10-19 1994-10-19 Flavin derivatives as anti-viral agents
IL11133894A IL111338A0 (en) 1993-10-19 1994-10-19 Pharmaceutical or veterinary compositions comprising flavin derivatives for the treatment of viral infections and their preparation
CZ961137A CZ113796A3 (en) 1993-10-19 1994-10-19 Flavin and derivatives thereof as antiviral active preparations
EP94930272A EP0739208A1 (en) 1993-10-19 1994-10-19 Flavin derivatives as anti-viral agents
UY23844A UY23844A1 (en) 1993-10-19 1994-10-19 ANTIVIROSIC AGENTS.
CN94194350A CN1140992A (en) 1993-10-19 1994-10-19 Flavin derivatives as anti-viral agents
EE9600057A EE9600057A (en) 1993-10-19 1994-10-19 Flavin derivatives for use as antiviral agents
ZA948191A ZA948191B (en) 1993-10-19 1994-10-19 Anti-viral agents
HR9321558.0A HRP940688A2 (en) 1993-10-19 1994-10-19 Anti-viral agents
AU79437/94A AU7943794A (en) 1993-10-19 1994-10-19 Flavin derivatives as anti-viral agents
GB9421099A GB2283913A (en) 1993-10-19 1994-10-19 Anti-viral agents comprising flavins
PCT/GB1994/002292 WO1995011028A1 (en) 1993-10-19 1994-10-19 Flavin derivatives as anti-viral agents
CO94047671A CO4520283A1 (en) 1993-10-19 1994-10-19 ANTIVIRAL AGENTS
PL94314008A PL314008A1 (en) 1993-10-19 1994-10-19 Derivatives of flavine as antiviral agents
BR9407862A BR9407862A (en) 1993-10-19 1994-10-19 Flavin compound flavin derived from flavin or a mixture comprising two or more of these pharmaceutical composition and process for treatment by prophylaxis or therapy of disease caused by viral infection
JP7511518A JPH09505804A (en) 1993-10-19 1994-10-19 Flavin derivatives as antiviral agents
APAP/P/1994/000695A AP620A (en) 1993-10-19 1994-10-19 Uses of a flavin in the treatment of ill-effects caused by viral infections.
GB9804302A GB2319474A (en) 1993-10-19 1994-10-19 Anti-viral agents
HU9601006A HUT76322A (en) 1993-10-19 1994-10-19 Flavin derivatives as anti-viral agents
OA60815A OA10579A (en) 1993-10-19 1996-04-18 Flavin derivatives as anti-viral agents
NO961547A NO961547L (en) 1993-10-19 1996-04-18 Flavin derivatives as anti-viral agents
BG100599A BG100599A (en) 1993-10-19 1996-05-17 Antiviral form and therapeutical method
MD96-0168A MD960168A (en) 1993-10-19 1996-05-17 Method for treatment of viral infections and compounds therefor
GBGB9801098.6A GB9801098D0 (en) 1993-10-19 1998-01-20 Anti-viral agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939321558A GB9321558D0 (en) 1993-10-19 1993-10-19 Anti-viral agents

Publications (1)

Publication Number Publication Date
GB9321558D0 true GB9321558D0 (en) 1993-12-08

Family

ID=10743784

Family Applications (2)

Application Number Title Priority Date Filing Date
GB939321558A Pending GB9321558D0 (en) 1993-10-19 1993-10-19 Anti-viral agents
GB9421099A Withdrawn GB2283913A (en) 1993-10-19 1994-10-19 Anti-viral agents comprising flavins

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB9421099A Withdrawn GB2283913A (en) 1993-10-19 1994-10-19 Anti-viral agents comprising flavins

Country Status (26)

Country Link
EP (1) EP0739208A1 (en)
JP (1) JPH09505804A (en)
CN (1) CN1140992A (en)
AP (1) AP620A (en)
AU (1) AU7943794A (en)
BG (1) BG100599A (en)
BR (1) BR9407862A (en)
CA (2) CA2123825A1 (en)
CO (1) CO4520283A1 (en)
CZ (1) CZ113796A3 (en)
EE (1) EE9600057A (en)
GB (2) GB9321558D0 (en)
HR (1) HRP940688A2 (en)
HU (1) HUT76322A (en)
IL (1) IL111338A0 (en)
JO (1) JO1866B1 (en)
MA (1) MA23356A1 (en)
MD (1) MD960168A (en)
NO (1) NO961547L (en)
OA (1) OA10579A (en)
PE (1) PE5596A1 (en)
PL (1) PL314008A1 (en)
SK (1) SK50696A3 (en)
UY (1) UY23844A1 (en)
WO (1) WO1995011028A1 (en)
ZA (1) ZA948191B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07188052A (en) * 1993-12-27 1995-07-25 Sanwa Kagaku Kenkyusho Co Ltd Interferon activity-enhancing agent and antivirus activity-enhancing composition containing the enhancing agent and interferon
US5756479A (en) * 1994-12-29 1998-05-26 Research Development Foundation Flavin adenine dinucleotide analogue inhibitors of monoamine oxidase
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
CA2492103A1 (en) * 2002-05-10 2004-05-27 The Ohio State University Flavin n-oxides: new anti-cancer agents and pathogen eradication agents
ITTO20020622A1 (en) 2002-07-16 2004-01-16 Dayco Europe Srl INTEGRATED PULLEY-TORSIONAL DAMPER GROUP
CN100413866C (en) * 2002-08-02 2008-08-27 中国人民解放军军事医学科学院放射医学研究所 Riboflavin derivative and its preparation method and uses
EP2545788A1 (en) * 2011-07-13 2013-01-16 Martin Hulliger Dietary multi-component system
JP2018131410A (en) * 2017-02-15 2018-08-23 ヒノキ新薬株式会社 Caspase-3 inhibitor and use thereof
RU2020116649A (en) * 2017-10-24 2021-11-30 Лунелла Байотек, Инк. MITOFLAVOSCINS: Targeting Flavin-Containing Enzymes Eliminates Malignant stem cells (CSCS) by inhibiting mitochondrial respiration
KR20220034163A (en) * 2019-07-09 2022-03-17 디에스엠 아이피 어셋츠 비.브이. Decreased viral activity of elafibrano and riboflavin or DHA

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219545A (en) * 1979-03-23 1980-08-26 Collins Calvin E Treatment of infectious keratoconjunctivitis in animals
US4264601A (en) * 1979-06-12 1981-04-28 The Board Of Regents Of The University Of Oklahoma Antihypertensive agents and their use in treatment of hypertension
US4500524A (en) * 1982-09-15 1985-02-19 Trustees Of Boston University Tranquilizing and reducing or preventing seizures
WO1991002529A2 (en) * 1989-08-14 1991-03-07 John Bennett Kizer Product and method for killing abnormal vertebrate cells
JP2727471B2 (en) * 1989-09-14 1998-03-11 三井農林株式会社 Influenza virus infection prevention agent
US5192264A (en) * 1989-10-06 1993-03-09 The Beth Israel Hospital Association Methods and apparatus for treating disease states using oxidized lipoproteins
US5217716A (en) * 1990-07-18 1993-06-08 The Beth Israel Hospital Association Method for treating viral infections using oxidized lipoproteins
FR2674753B1 (en) * 1991-04-02 1995-03-10 Jean Berque NEW THERAPEUTIC INDICATIONS, PARTICULARLY FOR THE TREATMENT OF AIDS, OF AN ALREADY EXISTING MEDICINAL PRODUCT FROM A DENIMOUS MOLECULE OF CONTRAINDICATIONS AND ADVERSE REACTIONS.
NZ244270A (en) * 1991-09-13 1995-07-26 Eisai Co Ltd Injectable composition comprising riboflavin
WO1993010784A1 (en) * 1991-11-25 1993-06-10 University Of Michigan Therapeutic composition and method for preventing reperfusion injury
JP3073309B2 (en) * 1992-03-27 2000-08-07 雪印乳業株式会社 Sialic acid-bound 5-deazaflavin compounds

Also Published As

Publication number Publication date
AU7943794A (en) 1995-05-08
CO4520283A1 (en) 1997-10-15
CN1140992A (en) 1997-01-22
OA10579A (en) 2002-06-19
PL314008A1 (en) 1996-08-05
MA23356A1 (en) 1995-07-01
BG100599A (en) 1997-02-28
HU9601006D0 (en) 1996-06-28
BR9407862A (en) 1997-05-20
EE9600057A (en) 1996-10-15
EP0739208A1 (en) 1996-10-30
NO961547D0 (en) 1996-04-18
HRP940688A2 (en) 1997-04-30
JPH09505804A (en) 1997-06-10
ZA948191B (en) 1995-06-08
AP620A (en) 1997-10-14
GB2283913A (en) 1995-05-24
JO1866B1 (en) 1995-12-27
UY23844A1 (en) 1995-03-28
SK50696A3 (en) 1997-01-08
HUT76322A (en) 1997-08-28
PE5596A1 (en) 1996-04-18
MD960168A (en) 1998-04-30
NO961547L (en) 1996-06-19
CZ113796A3 (en) 1996-11-13
GB9421099D0 (en) 1994-12-07
WO1995011028A1 (en) 1995-04-27
CA2123825A1 (en) 1995-04-20
AP9400695A0 (en) 1995-01-31
IL111338A0 (en) 1994-12-29
CA2174552A1 (en) 1995-04-27

Similar Documents

Publication Publication Date Title
DE69400639D1 (en) Rehydratationsgetraenk
DE69426415D1 (en) Intrapulmonares hormonabgabesystem
DE69421914D1 (en) Ekg-sensor
DE69401926D1 (en) Hydroxamsäurederivate
EP0699071A4 (en) Anti-viral guanosine-rich oligonucleotides
DE69406448D1 (en) Luftreinigungsgerät
DE69405713D1 (en) Carbonylierungsverfahren
DE69412242D1 (en) Orthopädisches gussmaterial
DE59407177D1 (en) 2-fluorcycloyhexen-derivate
GB9414754D0 (en) Anti-viral agent
DE69423875D1 (en) Hydrodealkylierungsverfahren
GB9321558D0 (en) Anti-viral agents
DE59409705D1 (en) 3-methoxy-2-phenyl-acrylsäuremethylester
GB9322576D0 (en) Antihaemostatic agents
DE59408644D1 (en) Jacquardmaschine
DE69408437D1 (en) Oxychlorierungsverfahren
DE59408733D1 (en) Metallhalogenidentladungslampe
DE59410065D1 (en) 3-methoxy-2-phenyl-acrylsäuremethylester
GB9212276D0 (en) Anti-viral agents
DE69425743D1 (en) Faserreaktive anthrachinon-farbstoffe
DE69412128D1 (en) Kühlcontainer
DE69410761D1 (en) Polyacetalharzzusammensetzung
DE69422299D1 (en) Photographisches reproduktionsgerät
DE69407946D1 (en) Oxychlorierungskatalysator
DE69413832D1 (en) Amidierungskatalysatorkonzentrat